Alembic Pharmaceuticals Limited — Credit Ratings, 26-07-2025: Credit Rating

Alembic Pharmaceuticals' long-term bank loan facilities have been reaffirmed by CRISIL at 'CRISIL AA+/Stable'. This action reflects CRISIL's consistent assessment of the company's strong financial health, stable liquidity, and robust business profile. Importantly, the rating was maintained even as the rated bank loan facilities were enhanced from Rs 600 Cr to Rs 800 Cr, though the company's overall borrowing limit remains unchanged. This reaffirmation is a positive signal, implying continued access to capital at favorable terms, which reinforces investor confidence and supports strategic operational flexibility for the company.